METASTATIC NEUROENDOCRINE NEOPLASM
Clinical trials for METASTATIC NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug cocktail shows promise against rare, aggressive cancer
Disease control OngoingThis study tested a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—in 17 people with advanced, poorly differentiated neuroendocrine cancer that had spread. The goal was to see if the treatment could shrink tumors or stop them from growing. The approach combine…
Matched conditions: METASTATIC NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Heart-Saving hope for neuroendocrine cancer patients?
Disease control OngoingThis study tests whether adding telotristat ethyl to standard therapy can help control carcinoid syndrome and reduce heart damage in people with advanced neuroendocrine tumors. About 79 adults with metastatic disease who are already on stable somatostatin analog therapy will part…
Matched conditions: METASTATIC NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 05, 2026 11:56 UTC